Hepatitis B drugs are being vastly underused, and boosting early treatment against the deadly hepatitis B virus (HBV) could save many lives over time, argued scientists in a new paper published in Lancet Gastroenterology and Hepatology.
Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.